An Expert Council resolution provides updated guidance on the use of acetylsalicylic acid for the primary prevention of cardiovascular diseases based on new scientific data.
Does acetylsalicylic acid prevent cardiovascular diseases in the context of primary prevention?
This document presents the resolution of a Russian Expert Council on the use of acetylsalicylic acid for primary prevention of cardiovascular diseases based on updated clinical guidelines.
Expert Council: Drapkina O. M., Vavilova T. V., Karpov Yu. A., Kobalava Zh. D., Lomakin N. V., Martynov A. I., Roitman E. V., Sychev D. A.Scientific communities: the Russian Society for the Prevention of Non-Communicable Diseases (ROPNIZ), the Russian Scientific Medical Society of Therapists (RNMOT), the Russian Antithrombotic Forum (RAF), the National Association for Thrombosis and Hemostasis (NATH).
Драпкина et al. (Tue,) conducted a review in Primary prevention of cardiovascular diseases. Acetylsalicylic acid was evaluated. An Expert Council resolution provides updated guidance on the use of acetylsalicylic acid for the primary prevention of cardiovascular diseases based on new scientific data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: